Healthcare
IQVIA Holdings Inc.(IQV)
Live Price
Offline$167.77
-1.70% today
1Y Change
+13.28%
Window
Jun 26, 2025 โ Jun 16, 2026
- Market Cap
- $26.77B
- Revenue Growth
- +5.9%
- EPS Growth
- +4.5%
- Dividend Yield
- 0.0%
Coverage: 244 bars ยท Jun 26, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
IQVIA Holdings Inc. (IQV) is a Healthcare stock with a market cap of $26.77B and listed on NYSE. The stock last traded around $167.77 and up 13.3% across the available one-year price window (Jun 26, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +5.9%, EPS growth of +4.5%, a dividend yield of 0.0%. What stands out right now is revenue +5.9%, EPS +4.5%, free cash flow -3.0% with operating margin 14.0% and ROIC 8.2%. Valuation is more restrained than many high-expectation growth names at P/E 19.7 and price/sales 1.6. Stock Foundry combines IQV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+5.9% vs +7.6% peer median
Operating Margin
Below sector median
+14.0% vs +19.4% peer median
P/E
Below sector median
19.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 5, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +5.9% and EPS at +4.5%, with operating margin around 14.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -3.6% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 5, 2026 | โ | +0.0% | -0.8% | +3.2% |
2026 Feb 5, 2026 | +0.6% | +3.6% | -6.7% | -3.6% |
2025 Oct 28, 2025 | +0.7% | -0.1% | -3.3% | +6.3% |
Benchmark Edge
IQV vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
IQV
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
IQV Max Drawdown
-35.87%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for IQV and SPY.
Company Overview
IQVIA Holdings Inc.
New York Stock Exchange
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
- Leadership
- Ari Bousbib
- IPO Date
- May 9, 2013
- Employees
- 89.0k
- Street Address
- 2400 Ellis Road
- Mailing
- Durham, NC, 27703
- Region
- Durham, NC, US
- Reporting Currency
- USD
- Investor Line
- 919 998 2000
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 19.7
- EV/EBITDA
- 11.8
- Price/Sales
- 1.6
- Price/Book
- 4.1
Growth
- Revenue
- +5.9%
- EPS
- +4.5%
- Free Cash Flow
- -3.0%
Profitability
- Gross Margin
- 26.3%
- Operating Margin
- 14.0%
- Net Margin
- 8.3%
- ROE
- 22.3%
- ROIC
- 8.2%
Balance Sheet
- Debt/Equity
- 2.49
- Current Ratio
- 0.75
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.